Sustainability as a concept was gaining good traction across industries, globally and in India, before the onset of the COVID-19pandemic. Be it reducing energy consumption or emission of greenhouse gases to curb environmental pollution, improving waste management or optimising water consumption, the pharma industry was identifying and implementing various measures to become more sustainable. Many companies were actively seeking to enhance their impact on the environment and society.
But, the focus of the world has shifted towards fighting the pandemic. For the pharma industry, in particular, identifying and developing new tests, medicines and vaccines at the earliest to fight COVID-19, while ensuring that the production and supply of other medicines remain unhampered, is the current priority. How has this affected sustainability agendas? Have they taken a back seat in this scenario? Let’s examine.
The COVID-19 impact
A GlobalData report had anticipated last year, “Sustainability was the buzzword of 2019 and would have continued to increase in prominence in 2020. However, the global outbreak of coronavirus (COVID-19) will bring progress to a halt.”
This year, in another report, GlobalData highlighted, “Sustainability has been a big trend in the past few years and many companies in the Asia-Pacific (APAC) region have switched to more eco-friendly alternatives, such as replacing plastic materials and removing single-use packaging. However, since the outbreak of coronavirus, companies may resort to plastic packaging to combat the spread of the pandemic putting the sustainability aspect in the back seat.”
This story is from the June 2021 edition of Express Pharma.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the June 2021 edition of Express Pharma.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation